Is Mark Cuban wrong about employers, PBMs & drug prices?

The billionaire Mark Cuban whose Cost Plus Drugs company has been shaking up the world of prescription drug coverage minces no words when it comes to the role of employers in bringing down healthcare costs. But some employers believe he is wrong.

Editor's Pick

Top Story Is Mark Cuban Wrong About Employers, PBMs and Drug Prices? The billionaire Mark Cuban whose Cost Plus Drugs company has been shaking up the world of prescription drug coverage minces no words when it comes to the role of employers in bringing down healthcare costs. But some employers believe he is wrong. Sponsored Make Moves—Join the Innovation Incubator in Chicago Presented by Society of Critical Care Medicine Explore what's next in healthcare. Investors and startups will connect with leading clinicians as breakthrough ideas are pitched and refined. Gain exclusive access to cutting-edge solutions, networking opportunities, and industry insights. Register now.

Featured News

Nearly 40,000 People Urge Employers to Cover Comprehensive Obesity Care Nearly 40,000 people have signed a petition from the Alliance for Women's Health and Prevention's EveryBODY Covered Campaign urging employers to recognize obesity as a chronic condition and expand comprehensive coverage. Despite Phase 3 Failure, Sarepta Still Sees Path for Muscle Disease Drugs to Secure Full FDA Approval Sarepta Therapeutics attributed the Phase 3 failure to the Covid-19 pandemic, during which many patients missed multiple doses of its Duchenne muscular dystrophy therapies. The company plans to discuss with the FDA traditional regulatory approvals based on the totality of data that includes real world evidence from the years these drugs have been commercially available under accelerated approvals. Medtronic Exec: AI Is Improving Device Launches & Patient Outcomes Jennifer Thompson, Medtronic's vice president of U.S. aortic sales, detailed how AI is transforming medical device commercialization during a fireside chat at Reuters' MedTech conference. The technology is helping teams identify patients, optimize their sales deployment and discover care bottlenecks. Therapy 2.0: An AI-Powered Science of Language Intervention By safety and cautiously integrating LLMs in a clinician setting, we have the potential for the ultimate levels of personalization: the perfect words for the right person at the right time. The Critical Role Payers Can Play in Closing the Oral Health Gap Salivary testing represents more than a new tool; it's a scalable strategy to shift care upstream, reduce preventable emergencies, and bring equity to a population too often left behind.

Video   Crypto in Healthcare Have you considered buying crypto as a corporate finance strategy? MedCity News' Debunked weighs in.

Resources

MedCity Pivot Podcast: A Chat With AWS Chief Medical Officer Rowland Illing Dr. Rowland Illing explained how life science companies and health systems are leveraing AWS HealthLake to transform healthcare. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe